UnitedHealth Group Incorporated (NYSE:UNH) Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
UnitedHealth Group Incorporated (NYSE UNH) traded down 0.34% during mid-day trading on Thursday, reaching $197.66. 2,378,644 shares of the company’s stock traded hands. UnitedHealth Group Incorporated has a 1-year low of $133.03 and a 1-year high of $200.76. The firm has a 50-day moving average price of $195.02 and a 200-day moving average price of $180.41. The stock has a market cap of $191.11 billion, a P/E ratio of 23.75 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period last year, the company earned $1.96 earnings per share. The firm’s revenue was up 7.7% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be issued a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (NYSE:UNH) Director Gail R. Wilensky Sells 5,600 Shares” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://ledgergazette.com/2017/09/15/unitedhealth-group-incorporated-unh-director-gail-r-wilensky-sells-5600-shares.html.
Several hedge funds and other institutional investors have recently bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC grew its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group in the second quarter valued at $110,000. Kings Point Capital Management grew its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. grew its stake in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares in the last quarter. Institutional investors own 86.21% of the company’s stock.
A number of brokerages have recently weighed in on UNH. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Cantor Fitzgerald restated a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, August 29th. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Finally, Cowen and Company restated an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. One research analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $203.41.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com’s FREE daily email newsletter.